Key facts
- Reev (Therapeutic Devices)’s last known valuation is $15.1M (Feb 2025).
- It has raised $12.6M.
- Notable investors include Techstars, Endless Frontier Labs, MassRobotics, Newfund Management, IRDI Capital Investissement — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Reev (Therapeutic Devices)
- ·The full record, as it builds
Funding rounds
No funding rounds for Reev (Therapeutic Devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Reev (Therapeutic Devices)
Developer of a robotic orthosis device designed to diminish muscle fatigue, facilitate daily trips and improve life quality. The company's device is lightweight and personalized for the patients which helps gain muscle strength by performing resistive exercises, enabling patients to walk longer, stand up, sit down and take stairs with ease.
- Sector
- Healthcare
- HQ
- Labège, France
- Founded
- 2021
- Employees
- 38
- Website
- reev.care/
- Ownership
- Privately Held (backing)
Reev (Therapeutic Devices) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Reev (Therapeutic Devices) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Reev (Therapeutic Devices) in its N-PORT filings yet. We sweep new filings monthly.